Clinical Variant Reclassification in Hereditary Disease Genetic Testing.

Overall, we observed a clear trend where VUS with more pathogenic evidence were more likely to be reclassified as LP or pathogenic, while VUS with more benign evidence were more likely to be reclassified as LB or benign.

also in 19,460 other papers